Birch Pollen Allergy - Pipeline Review, H2 2011

Document Sample
Birch Pollen Allergy - Pipeline Review, H2 2011 Powered By Docstoc
					Birch Pollen Allergy – Pipeline Review, H2 2011




             Birch Pollen Allergy - Pipeline Review, H2 2011
                                                                                          Reference Code: GMDHC1516IDB

                                                                                          Publication Date: November 2011




Birch Pollen Allergy – Pipeline Review, H2 2011                                                               GMDHC1516IDB / Pub November 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                                Page(1)
Birch Pollen Allergy – Pipeline Review, H2 2011



Ta b le o f Co n te n ts
Table of Contents ..................................................................................................................................................................................................... 2
      List of Tables...................................................................................................................................................................................................... 4
      List of Figures .................................................................................................................................................................................................... 5
Introduction .............................................................................................................................................................................................................. 6
      Global Markets Direct Report Coverage ............................................................................................................................................................. 6
Birch Pollen Allergy Overview ................................................................................................................................................................................... 7
Therapeutics Development ....................................................................................................................................................................................... 8
      An Overview of Pipeline Products for Birch Pollen Allergy .................................................................................................................................. 8
Birch Pollen Allergy Therapeutics under Development by Companies .....................................................................................................................10
Birch Pollen Allergy Therapeutics under Investigation by Universities/Institutes .......................................................................................................11
Late Stage Products ................................................................................................................................................................................................12
      Comparative Analysis .......................................................................................................................................................................................12
Mid Clinical Stage Products .....................................................................................................................................................................................13
      Comparative Analysis .......................................................................................................................................................................................13
Early Clinical Stage Products ..................................................................................................................................................................................14
      Comparative Analysis .......................................................................................................................................................................................14
Discovery and Pre-Clinical Stage Products..............................................................................................................................................................15
      Comparative Analysis .......................................................................................................................................................................................15
Birch Pollen Allergy Therapeutics - Products under Development by Companies ....................................................................................................16
Birch Pollen Allergy Therapeutics - Products under Investigation by Universities/Institutes......................................................................................17
Companies Involved in Birch Pollen Allergy Therapeutics Development ..................................................................................................................18
      ALK-Abello A/S .................................................................................................................................................................................................18
      Paladin Labs Inc................................................................................................................................................................................................18
      Allergopharma Joachim Ganzer KG ..................................................................................................................................................................19
      Circassia Holdings Ltd.......................................................................................................................................................................................19
      ImVisioN Therapeutics AG ................................................................................................................................................................................20
      Biomay AG........................................................................................................................................................................................................20
Birch Pollen Allergy - Therapeutics Assessment ......................................................................................................................................................21
      Assessment by Monotherapy Products .............................................................................................................................................................21
      Assessment by Combination Products ..............................................................................................................................................................22
      Assessment by Route of Administration ............................................................................................................................................................23
      Assessment by Molecule Type ..........................................................................................................................................................................25
Drug Profiles ...........................................................................................................................................................................................................27
      Birch Pollen Allergoid - Drug Profile ..................................................................................................................................................................27
            Product Description ....................................................................................................................................................................................27
            Mechanism of Action...................................................................................................................................................................................27
            R&D Progress .............................................................................................................................................................................................27
      AL0206st - Drug Profile .....................................................................................................................................................................................28
            Product Description ....................................................................................................................................................................................28
            Mechanism of Action...................................................................................................................................................................................28
            R&D Progress .............................................................................................................................................................................................28
      ALK Birch Pollen Vaccine - Drug Profile ............................................................................................................................................................29
            Product Description ....................................................................................................................................................................................29
            Mechanism of Action...................................................................................................................................................................................29
            R&D Progress .............................................................................................................................................................................................29
      IVN-Birch - Drug Profile .....................................................................................................................................................................................30
            Product Description ....................................................................................................................................................................................30


Birch Pollen Allergy – Pipeline Review, H2 2011                                                                                                           GMDHC1516IDB / Pub November 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                                                                                                                Page(2)
Birch Pollen Allergy – Pipeline Review, H2 2011


            Mechanism of Action...................................................................................................................................................................................30
            R&D Progress .............................................................................................................................................................................................30
      Recombinant Birch Pollen Allergen - Drug Profile..............................................................................................................................................31
            Product Description ....................................................................................................................................................................................31
            Mechanism of Action...................................................................................................................................................................................31
            R&D Progress .............................................................................................................................................................................................31
      Staller - Drug Profile ..........................................................................................................................................................................................32
            Product Description ....................................................................................................................................................................................32
            Mechanism of Action......................................................................................................................................
				
DOCUMENT INFO
Description: Birch Pollen Allergy - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Birch Pollen Allergy - Pipeline Review, H2 2011', provides an overview of the Birch Pollen Allergy therapeutic pipeline. This report provides information on the therapeutic development for Birch Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Birch Pollen Allergy. 'Birch Pollen Allergy - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Birch Pollen Allergy. - A review of the Birch Pollen Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Birch Pollen Allergy pipeline on the basis of route of administration and molecule type. - Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Birch Pollen Allergy. - Identify emerging players with potentially strong product
BUY THIS DOCUMENT NOW PRICE: $500 100% MONEY BACK GUARANTEED
PARTNER GlobalMarketsDirect
Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. Global Markets Direct has a broad range of coverage over key market segments. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries